AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

Researchers have developed a simple model system that can be used to break down fibrils -- the cause of numerous disorders including Alzheimer's and Parkinson's disease -- into their constituent ...

to develop exercise equipment for Parkinson’s Disease patients in the area. One result of Hunter’s efforts includes a machine ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...

Could your dreams be trying to tell you something? Discover the surprising connections between what haunts you at night and ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an anti-alpha-synuclein (a-syn) active immunotherapy for early Parkinson’s disease (PD).

Emmerdale viewers have their first hints at a Christmas storyline on the ITV soap in new spoilers, amid the news one fan ...

An international research team has uncovered a new mechanism crucial to the production of cellular proteins. When this ...

The connection between auditory or vestibular disorders and neuroinflammatory or neurodegenerative diseases has gained ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...